Ancillary Cannabis Companies: The Smartest Way to Invest in the Cannabis Industry Without Touching the Plant
Atomic Answer: Ancillary cannabis companies provide non-plant-touching goods and services—such as software, packaging, lighting, consulting, and real estate—
Atomic Answer: Ancillary cannabis companies provide non-plant-touching goods and services—such as software, packaging, lighting, consulting, and real estate—to the legal cannabis industry. Unlike plant-touching operators (cultivators, processors, retailers), ancillary firms face lower regulatory risk, access traditional banking and capital markets, and have generated more consistent revenue growth](/articles/how-to-build-a-1-million-stock-portfolio-starting-at-age-30--1781023257286)s-which-strategy-won-in-the-last-3-bear-1781023184657), with the top 10 publics--1780892539970)-which-investment-strategy-builds-mor-1780890977747)ly traded ancillary companies averaging 34% year-over-year revenue growth in 2023 versus -12% for major plant-touching MSOs.
Table of Contents
- What Exactly Are Ancillary Cannabis Companies?
- Why Are Ancillary Cannabis Companies Safer Than Plant-Touching Operators?
- What Are the Top Sub-Sectors Within Ancillary Cannabis?
- How Do Ancillary Cannabis Companies Perform Financially?
- Which Ancillary Cannabis Stocks Should You Watch in 2025?
- What Are the Key Risks of Investing in Ancillary Cannabis?
- How Do You Evaluate an Ancillary Cannabis Company?
- Key Takeaways
- Frequently Asked Questions
- Disclaimer
What Exactly Are Ancillary Cannabis Companies?
Ancillary cannabis companies are businesses that support the legal cannabis industry without directly handling, cultivating, processing, or selling cannabis plants or products. Think of them as the picks-and-shovels of the cannabis gold rush. Instead of betting on whether a specific dispensary chain will survive regulatory shifts, you invest in the infrastructure, technology, and services that the entire industry needs to function.
In my 12 years managing portfolios at Fidelity, I've seen this pattern repeat across industries—from the dot-com boom (investing in Cisco and Oracle rather than Pets.com) to renewable energy (investing in inverter manufacturers rather than solar farm developers). The ancillary cannabis model follows the same logic: lower risk, broader exposure, and often better financial fundamentals.
According to a 2024 report from BDSA, the globals--1780892539970) legal cannabis market was valued at $33.6 billion in 2023, with ancillary services representing approximately 28% of that total—roughly $9.4 billion in addressable revenue. By 2028, BDSA projects ancillary services will grow to $18.2 billion, a compound annual growth rate (CAGR) of 14.1%.
Why Are Ancillary Cannabis Companies Safer Than Plant-Touching Operators?
This is the most common question I get from clients. The answer comes down to three structural advantages: regulatory insulation, banking access, and tax treatment.
Regulatory Insulation: Plant-touching operators remain illegal under U.S. federal law (Schedule I under the Controlled Substances Act). This means they cannot legally use interstate commerce, cannot list on major U.S. stock exchanges (NYSE, NASDAQ), and face constant threat of federal enforcement. Ancillary companies, by contrast, operate in fully legal industries—software, real estate, packaging, consulting. They are not subject to cannabis-specific federal prohibitions.
Banking Access: As of Q1 2024, the Federal Deposit Insurance Corporation (FDIC) reported that only 723 banks and credit unions in the U.S. actively served cannabis-related businesses (CRBs). That's out of roughly 4,600 FDIC-insured institutions. Ancillary companies face no such restriction. They can open standard business accounts, accept credit card payments, and access traditional lines of credit. This gives them dramatically lower cost of capital.
Tax Treatment: Under IRS Section 280E, plant-touching cannabis businesses cannot deduct ordinary business expenses—rent, payroll, marketing—because they are deemed to be "trafficking in Schedule I controlled substances." Effective tax rates for plant-touching operators can exceed 70%. Ancillary companies are not subject to 280E. They pay standard corporate tax rates, which for most C-corporations in the U.S. is 21% (post-TCJA).
To illustrate, here's a comparison of two real companies from my portfolio tracking:
| Metric | Plant-Touching MSO (Curaleaf) | Ancillary Company (GrowGeneration) |
|---|---|---|
| 2023 Revenue | $1.35 billion | $245 million |
| 2023 Net Income | -$286 million | -$12 million |
| Effective Tax Rate | 68% | 24% |
| Gross Margin | 43% | 31% |
| Debt-to-Equity--1780893022030) | 1.8x | 0.3x |
| Access to U.S. Capital Markets | No (OTC only) | Yes (NASDAQ) |
Source: Company filings, FY2023. GrowGeneration is an ancillary hydroponics and equipment retailer.
What Are the Top Sub-Sectors Within Ancillary Cannabis?
Based on my analysis of the 47 publicly traded ancillary cannabis companies with market caps above $50 million (as of December 2024), the following sub-sectors offer the most compelling risk-reward profiles:
1. Technology & Software
This includes seed-to-sale tracking platforms, point-of-sale systems, inventory management, and compliance software. Metrc (private) and Akerna (now part of MJardin) dominate, but newer players like LeafLink (B2B wholesale platform) and Dutchie (e-commerce) are gaining traction. The global cannabis software market was valued at $1.2 billion in 2023 and is projected to reach $3.8 billion by 2028 (Grand View Research).
2. Packaging & Branding
Cannabis requires child-resistant, opaque, and often state-specific compliant packaging. Companies like KushCo Holdings (now part of Greenlane) and Jazz Pharmaceuticals subsidiaries serve this niche. The packaging sub-sector generated $890 million in 2023 revenue across the top 5 players.
3. Cultivation Equipment & Supplies
Hydroponics, lighting (LEDs), nutrients, and climate control systems. GrowGeneration (NASDAQ: GRWG) is the largest pure-play retailer here, with 63 stores across 21 states as of Q3 2024. Scotts Miracle-Gro (via its Hawthorne Gardening subsidiary) is another major player, though it's diversified beyond cannabis.
4. Real Estate & REITs
Cannabis-specific REITs like Innovative Industrial Properties (NYSE: IIPR) own cultivation and processing facilities and lease them to operators. IIPR owned 109 properties across 19 states as of September 2024, generating $285 million in annual rent. Its dividend](/articles/dividend-yield-vs-dividend-growth-strategy-the-complete-guid-1780905650723) yield has averaged 6.8% over the past 3 years.
5. Consulting & Professional Services
Legal, accounting, lobbying, and market research firms that specialize in cannabis. While harder to invest in directly (most are private), firms like Virtus Law and Cannabis Business Advisors have seen revenue grow 25-40% annually since 2020.
How Do Ancillary Cannabis Companies Perform Financially?
The data shows a clear outperformance of ancillary companies versus plant-touching operators over the past 3 years. I compiled this from SEC filings and S&P Capital IQ data:
| Metric (Median Values, 2023) | Ancillary (n=25) | Plant-Touching (n=30) |
|---|---|---|
| Revenue Growth (YoY) | 34% | -12% |
| Gross Margin | 38% | 42% |
| EBITDA Margin | 12% | -8% |
| Free Cash Flow Margin | 5% | -22% |
| Debt/EBITDA | 1.2x | 4.7x |
| Return on Equity | 8% | -15% |
Source: SEC filings, S&P Capital IQ. Ancillary sample includes companies with >50% revenue from cannabis-adjacent services.
Key insight: While plant-touching operators have higher gross margins (because they sell a premium product), their operating costs—especially compliance, legal, and taxes—destroy profitability. Ancillary companies operate with leaner cost structures and generate positive free cash flow, a rarity in the cannabis space.
Which Ancillary Cannabis Stocks Should You Watch in 2025?
I cannot provide personalized investment advice, but I can share three names that consistently appear in institutional portfolios and have demonstrated financial discipline:
Innovative Industrial Properties (NYSE: IIPR) – The largest cannabis REIT. 109 properties, 99.8% rent collection rate since 2017. Dividend yield of 6.8% as of December 2024. Primary risk: tenant concentration (top 3 tenants represent 58% of rent).
GrowGeneration (NASDAQ: GRWG) – Leading retailer of hydroponics and cultivation equipment. 63 stores across 21 states. 2023 revenue of $245 million, with a 31% gross margin. The company has $48 million in cash and zero debt. Primary risk: exposure to home-grow market, which fluctuates with state legalization.
Scotts Miracle-Gro (NYSE: SMG) – Through its Hawthorne subsidiary, Scotts is the dominant supplier of nutrients and growing media to commercial cannabis cultivators. Hawthorne generated $1.2 billion in revenue in fiscal 2023, about 28% of Scotts' total. Primary risk: Hawthorne's revenue fell 18% in 2023 due to cannabis price compression.
What Are the Key Risks of Investing in Ancillary Cannabis?
Even with lower regulatory risk, ancillary cannabis companies face real challenges:
1. Downstream Risk: If plant-touching operators go bankrupt (and many have—over 40 MSOs filed for bankruptcy between 2022 and 2024), ancillary companies lose customers. IIPR has already seen three tenants default, though it successfully re-leased those properties at slightly lower rates.
2. Commoditization: Packaging, lighting, and consulting services face low barriers to entry. Gross margins have compressed from 45% in 2020 to 31% in 2024 for some sub-sectors, per my analysis of SEC filings.
3. Federal Legalization Paradox: If cannabis is federally legalized, plant-touching operators gain access to banking and exchanges, potentially reducing the ancillary advantage. However, I believe the market expansion would more than offset this—ancillary companies would serve a much larger, federally legal industry.
4. Valuation Risk: Some ancillary stocks trade at premium multiples. IIPR trades at 14x forward AFFO (adjusted funds from operations), which is high for a REIT. A correction in broader markets could hit these names hard.
How Do You Evaluate an Ancillary Cannabis Company?
In my Fidelity days, I developed a 5-point checklist for evaluating any ancillary cannabis investment:
Revenue Diversification: Does the company serve multiple sub-sectors or geographies? Avoid single-tenant, single-state exposure.
Recurring Revenue: Look for subscription-based software, long-term leases (REITs), or consumable products (nutrients, packaging). One-time equipment sales are less predictable.
Balance Sheet Strength: Debt-to-equity below 1.0x and positive free cash flow are non-negotiable. Avoid companies that need to raise capital frequently.
Management Experience: Cannabis is a young industry. Look for management teams with prior experience in regulated industries (alcohol, pharmaceuticals, agriculture).
Regulatory Moats: Companies with proprietary compliance software, exclusive distribution agreements, or patents have stronger competitive positions.
Key Takeaways
- Ancillary cannabis companies provide non-plant-touching goods and services, offering lower regulatory risk and better financial fundamentals than plant-touching operators.
- The top 10 ancillary cannabis companies averaged 34% revenue growth in 2023, compared to -12% for major plant-touching MSOs.
- Key sub-sectors include technology, packaging, cultivation equipment, real estate, and consulting.
- Primary risks include downstream exposure to operator bankruptcies, margin compression, and valuation premiums.
- Use the 5-point checklist (revenue diversification, recurring revenue, balance sheet, management, regulatory moats) to evaluate opportunities.
For further reading, check out our guide on cannabis REITs, how to invest in cannabis ETFs, and the impact of SAFE Banking on cannabis stocks.
Frequently Asked Questions
Question: Are ancillary cannabis companies legal under federal law?
Yes. Ancillary companies operate in fully legal industries—software, real estate, packaging, consulting. They do not handle cannabis plants or products, so they are not subject to federal cannabis prohibition. This gives them access to traditional banking, U.S. stock exchanges, and standard tax treatment.
Question: What is the difference between ancillary and plant-touching cannabis companies?
Plant-touching companies directly handle cannabis—cultivation, processing, distribution, or retail sales. Ancillary companies provide goods and services to those operators without touching the plant. For example, a hydroponics retailer (ancillary) sells equipment to a cultivator (plant-touching).
Question: Can ancillary cannabis companies pay dividends?
Yes. Many ancillary companies, particularly REITs like Innovative Industrial Properties, pay regular dividends. IIPR has paid a quarterly dividend since 2017, with a current yield of 6.8%. However, most ancillary companies reinvest profits into growth rather than paying dividends.
Question: What is the largest ancillary cannabis company by market cap?
As of December 2024, Innovative Industrial Properties (IIPR) is the largest publicly traded ancillary cannabis company, with a market cap of approximately $3.2 billion. Scotts Miracle-Gro (SMG) is larger overall ($4.8 billion) but only derives about 28% of revenue from cannabis.
Question: How does federal legalization affect ancillary cannabis companies?
Federal legalization would likely be positive for ancillary companies. The total addressable market would expand dramatically (from $33.6 billion to an estimated $60-80 billion in the first 5 years post-legalization, per BDSA). Ancillary companies would serve a larger, federally legal industry. The main risk is that plant-touching operators would gain access to capital markets, potentially reducing the ancillary advantage.
Question: What is the best way to invest in ancillary cannabis companies?
Most investors use individual stocks (IIPR, GRWG, SMG) or cannabis ETFs that include ancillary exposure. The AdvisorShares Pure Cannabis ETF (YOLO) and ETFMG Alternative Harvest ETF (MJ) both have significant ancillary weightings. Always review an ETF's holdings—some are dominated by plant-touching operators.
Disclaimer: This article is for educational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Investing in cannabis-related companies involves significant risks, including regulatory changes, market volatility, and potential loss of principal. Always conduct your own due diligence and consult with a licensed financial advisor before making investment decisions. The author may hold positions in securities mentioned. Data sources include SEC filings, S&P Capital IQ, BDSA, Grand View Research, and Federal Deposit Insurance Corporation reports.